Biomedical consequences of alcohol use disorders in the HIV-infected host

Current HIV Research

Volumn 12, Issue 4, 2014, Pages 265-275

  Molina, Patricia E ^a   Bagby, Gregory J ^a   Nelson, Steve ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aids; Alcohol; Cytokines; Immune; Muscle wasting; SIV

Indexed keywords

PROTEASOME; UBIQUITIN;

ALCOHOL USE DISORDER; ARTICLE; BODY COMPOSITION; BODY MASS; COGNITIVE DEFECT; COMORBIDITY; DISEASE COURSE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; MORBIDITY; MUSCLE ATROPHY; NEUROLOGIC DISEASE; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRIMATE MODEL; TISSUE INJURY; TREATMENT OUTCOME; VIRUS INFECTIVITY; VIRUS REPLICATION; WASTING SYNDROME; AIDS DEMENTIA COMPLEX; ALCOHOLISM; COMPLICATION; DISEASE TRANSMISSION; HIGH RISK BEHAVIOR; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; PATHOLOGY; TRANSMISSION; UNITED STATES;

AIDS DEMENTIA COMPLEX; ALCOHOLISM; DISEASE PROGRESSION; DISEASE TRANSMISSION, INFECTIOUS; HIV; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; RISK-TAKING; UNITED STATES;

EID: 84906272591     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X12666140721121849     Document Type: Article

References (185)

1. Centers for Disease Control and Prevention. 2000. HIV AIDS surveillance report. U.S. HIV and AIDS cases reported through June 2000, Vol 12 No 1.
2. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007; 64 (7): 830-42.
3. Grant BF, Harford TC, Dawson DA, et al. Prevalence of DSM-IV alcohol abuse and dependence; United States, Alcohol Health and Research World. 1994; 18(3): 243-248.
4. Lefevre F, O'Leary B, Moran M, et al. Alcohol consumption among HIV-infected patients. J Gen Intern Med. 1995; 10(8): 458-60.
5. Lee LM, Karon JM, Selik R, et al. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA 2001; 285(10): 1308-15.
6. Samet JH, Phillips SJ, Horton NJ, et al. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses. 2004; 20 (2): 151-5.
7. Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002; 63(2): 179-86.
8. Kalichman SC, Amaral CM, White D, et al. Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Pt Care and STDs. 2009; 23(6): 449-54.
9. Greenfield TK, Midanik LT, Rogers JD. A 10-year national trend study of alcohol consumtion, 1984-1995: Is the period of declining drinking over? Am J Public Health. 2000; 90(1): 47-52.
10. Michel L, Carrieri MP, Fugon L, et al. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): Relevance for clinical management and intervention. AIDS Care. 2010; 22(9): 1136-45.
11. Phillips SJ, Freedberg KA, et al. Screening for alcohol problems in HIV-infected primary care patients. J Gen Intern Med. 2001; 16: 165.
12. Samet JH, Cheng DM, Libman H, et al. Alcohol consumption and HIV disease progression.J Acquir Immune Defic Syndr. 2007; 46(2): 194-9.
13. Molina PE, Hoek JB, Nelson S, et al. Mechanisms of Alcohol- Induced Tissue Injury. Alcohol Clin Exp Res. 2003; 27 (3): 563-75.
14. Gardner, MB, PA Luciw. Simian immunodeficiency viruses and their relationship to the human immunodeficiency virus. AIDS. 1998; 2: 3-10.
15. Arthur, LO, VG Raymond, P Marx, Gardner MB. Simian acquired immunodeficiency syndrome. Prog Allergy 1986; 37: 332-52.
16. Mohri H, Bonhoeffer S, Monard S, et al. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 1998; 279: 1223-27.
17. McClure HM, Anderson DC, Ansari AA, et al. Nonhuman primate models for evaluation of AIDS therapy. Ann N Y Acad Sci 1990; 616: 287-98.
18. Baskin GB, Murphey-Corb M, Watson EA et al. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/Delta. Vet Pathol 1988; 25: 456-67.
19. Bagby GJ, Zhang P, Purcell JE, et al. Chronic binge ethanol consumption accelerates progression of simian immunodeficiency virus disease. Alcohol Clin Exp Res. 2006 Oct; 30(10): 1781-90. PubMed PMID: 17010145.
20. Molina PE, McNurlan M, Rathmacher J, et al. Chronic Alcohol Accentuates Nutritional, Metabolic, and Immune Alterations During Asymptomatic Simian Immunodeficiency Virus Infection. Alcohol Clin Exp Res. 2006; 30(12): 2065-78.
21. Winsauer PJ, Moerschbaecher JM, Brauner IN, et al. Alcohol unmasks simian immunodeficiency virus-induced cognitive impairments in rhesus monkeys. Alcohol Clin Exp Res. 2002 Dec; 26(12): 1846-57. PubMed PMID: 12500109.
22. Centers for Disease Control and Prevention. 2002. Drug-associated HIV transmission continues in the United States.
23. Marcondes MC, Watry D, Zandonatti M, et al. Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques. Alcohol Clin Exp Res. 2008 Sep; 32(9): 1583-92. doi: 10.1111/j.1530-0277.2008.00730.x. Epub 2008 Jul 9. PubMed PMID: 18616669; PubMed Central PMCID: PMC2579901.
24. Liu X, Zha J, Nishitani J, et al. HIV-1 infection in peripheral blood lymphocytes (PBLs) exposed to alcohol. Virology 2003; 307(1): 37-44.
25. Zheng J, Yang OO, Xie Y, et al. Ethanol stimulation of HIV infection of oral epithelial cells. J Acquir Immune Defic Syndr. 2004; 37(4): 1445-53.
26. Bagasra O, Kajdacsy-Balla A, Lischner HW, et al. Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis. 1993; 167(4): 789-97.
27. Kumar R, Perez-Casanova AE, Tirado G, et al. Increased viral replication in simian immunodeficiency virus/simian-HIV-infected macaques with self-administering model of chronic alcohol consumption. J Acquir Immune Defic Syndr. 2005; 39(4): 386-90.
28. Pahar B, Amedee AM, Thomas J, et al. Effects of alcohol consumption on antigen-specific cellular and humoral immune responses to SIV in rhesus macaques. J Acquir Immune Defic Syndr. 2013 Jun 24. [Epub ahead of print] PubMed PMID: 23799411.
29. Poonia B, Nelson S, Bagby GJ, et al. Chronic alcohol consumption results in higher simian immunodeficiency virus replication in mucosally inoculated rhesus macaques. AIDS Res Hum Retroviruses. 2005 Oct; 21(10): 863-8. Erratum in: AIDS Res Hum Retroviruses. 2006 Aug; 22(8): 824. Corrected and republished in: AIDS Res Hum Retroviruses. 2006 Jun; 22 (6): 589-94.PubMed PMID: 16225413.
30. Nelson S, Happel KI, Zhang P, et al. Effect of bacterial pneumonia on lung simian immunodeficiency virus (SIV) replication in alcohol consuming SIV-infected rhesus macaques. Alcohol Clin Exp Res. 2013 Jun; 37(6): 969-77. doi: 10.1111/acer.12070.
31. Fuller CL, Choi YK, Fallert BA, et al. Restricted SIV replication in rhesus macaque lung tissues during the acute phase of infection. Am J Pathol. 2002 Sep; 161(3): 969-78. PubMed PMID: 12213725; PubMed Central PMCID: PMC1867265.
32. Dhillon NK, Pinson D, Dhillon S, et al.Bleomycin treatment causes enhancement of virus replication in the lungs of SHIV- infected macaques. Am J Physiol Lung Cell Mol Physiol. 2007 May; 292(5): L123-140. Epub 2007 Jan 12.
33. Segal LN, Methé BA, Nolan A, et al. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc. 2011 Jun; 8(3): 282-7. doi: 10.1513/pats.201006-044WR. Review. PubMed PMID: 21653529; PubMed Central PMCID: PMC3132786.
34. Boé DM, Nelson S, Zhang P, et al. Alcohol-induced suppression of lung chemokine production and the host defense response to Streptococcus pneumoniae. Alcohol Clin Exp Res. 2003 Nov; 27(11): 1838-45. PubMed PMID: 14634502.
35. Siggins RW, Melvan JN, Welsh DA, et al. Alcohol suppresses the granulopoietic response to pulmonary Streptococcus pneumonia infection with enhancement of STAT3 signaling. J Immunol. 2011 Apr
36. Theall KP, Amedee A, Clark RA, et al. Alcohol consumption and HIV-1 vaginal RNA shedding among women. J Stud Alcohol Drugs. 2008; 69(3): 454-8.
37. Potula R, Haorah J, Knipe B, et al. Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis. Am J Pathol. 2006; 168(4): 1335-44.
38. Pfefferbaum A, Rosenbloom MJ, Sassoon SA, et al. Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age. Biol Psychiatry. 2012 Sep 1; 72(5): 361-70. doi: 10.1016/j.biopsych.2012.02.018. Epub 2012 Mar 27. PubMed PMID: 22458948; PubMed Central PMCID: PMC3393798.
39. Fama R, Eisen JC, Rosenbloom MJ, et al. Upper and lower limb motor impairments in alcoholism, HIV infection, and their comorbidity. Alcohol Clin Exp Res.2007; 31(6): 1038-44.
40. Rothlind JC, Greenfield TM, Bruce AV, et al. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int NeuropsycholSoc. 2005; 11(1): 70-83.
41. Sassoon SA, Fama R, Rosenbloom MJ, et al. Component cognitive and motor processes of the digit symbol test: differential deficits in alcoholism, HIV infection, and their comorbidity. Alcohol Clin Exp Res.2007; 31(8): 1315-24.
42. Fama R, Rosenbloom MJ, Sassoon SA, et al. Remote semantic memory for public figures in HIV infection, alcoholism, and their comorbidity Alcoholism: Clinical and Experimental Research 2011; 35: 265-276
43. Dube B, Benton T, Cruess DG, et al. Neuropsychiatric manifestations of HIV infection and AID Journal of Psychiatry and Neuroscience. 2005; 30; 237-246
44. Sullivan LE, Saitz R, Cheng DM, et al. The impact of alcohol use on depressive symptoms in human immunodeficiency virusinfected patients Addiction.2008; 103: 1461-146740.
45. Fergusson DM, Boden JM, Horwood LJ Tests of causal links bewteen alcohol abuse or dependence and major depression. Archives of General Psychiatry. 2009; 66: 260-266
46. Preedy VR, Salisbury JR, Peters TJ. Alcoholic muscle disease: features and mechanisms. J. Pathol 1994; 173: 309-315.
47. Reilly ME, Mantle D, Richardson PJ, et al. Studies on the time course of ethanol's acute effects on skeletal muscle protein synthesis: comparison with acute changes in proteolytic activity. Alcohol Clin Exp Res 1997; 21(5): 792-798.
48. Pacy, PJ, Preedy VR, Peters TJ, et al. The effect of chronic alcohol ingestion on whole body and muscle protein synthesis- A stable isotope study. Alcohol & Alcoholism 1991; 26: 505-513, 1991.
49. Lang CH, Wu D, Frost RA, et al. Inhibition of muscle protein synthesis by alcohol is associated with modulation of eIF2B and eIF4E. Am J Physiol 1999; 277: 268-276.
50. Pruznak AM, Hong-Brown L, Lantry R, et al. Skeletal and cardiac myopathy in HIV-1 transgenic rats. AmJ Physiol EndocrinolMetab. 2008 Oct: 295(4): E96473. doi: 10.1152/ajpendo. 90482.2008. Epub2008Aug19. PubMed PMID: 18713959; PubMed Central PMCID: PMC2575896.
51. Clary CR, Guidot DM, Bratina MA, et al. Chronic alcohol ingestion exacerbates skeletal muscle myopathy in HIV-1 transgenic rats. AIDS Res Ther. 2011 Aug 16; 8: 30. doi: 10.1186/1742-6405-8-30.PubMed PMID: 21846370; PubMed Central PMCID: PMC3170178.
52. Keusch GT, Farthing MJG. Nutritional aspects of AIDS. Ann Rev Nutr 1990; 10: 475-501.
53. Brennan MF. Uncomplicated starvation versus cancer cachexia. Cancer Res 1997; 37: 2359-64.
54. Lang CH, Frost RA, Deshpande N, Kumar et al. Alcohol impairs leucine-mediated phosphorylation of 4E-BP1, S6K1, eIF4G, and mTOR in skeletal muscle. Am J Physiol Endocrinol Metab. 2003; 285(6): E1205-15.
55. McNurlan MA, Garlick PJ, Steigbigel RT, et al. Responsiveness of muscle protein synthesis to growth hormone administration in HIVinfected individuals declines with severity of disease. J. Clin. Invest. 1997; 100: 2125-2132.
56. Yarasheski K, Zachwieja JJ, Gischler J, et al. Increased plasma Gln and Leu Ra and inappropriate low muscle protein synthesis rate in AIDS wasting. Am J Physiol 1998; 275: E577-E583.
57. Tiao GM, Fagan J, Lieberman M, et al. Sepsis increases proteasome-dependent proteolysis and mRNA levels for the proteasome subunit RC3 in skeletal muscle. Surg. Forum.1995; 46: 10-12.
58. Yarasheski KE, Smith SR, Powderly WG. Reducing plasma HIV RNA improves muscle amino acid metabolism. Am J Physiol Endocrinol Metab 2005; 288: E278-E284.
59. Bailey JL, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J. Clin. Invest. 1996; 97: 1447-1453.
60. Molina PE, Tiao G, Meijerink J, et al. Sepsis-induced increase in brain endogenous morphine: regulator of proteolysis. Surg. Forum XLVI 1995; 4-6.
61. Tiao G, Fagan JM, Samuels N, et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 1994; 94: 2255-2264.
62. Fang CH, Tiao G, James JH, et al. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitinenergy- dependent pathway. J. Am. Coll. Surg.1995; 180: 161-70.
63. Llovera M, Garcia-Martinez C, Agell N, et al. Ubiquitin gene ex expression is increased in skeletal muscle of tumor-bearing rats. FEBS Lett. 1994; 338: 311-18.
64. Hasselgren PO. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism. Mol Biol Rep 1999; 26(1-2): 71-6.
65. Suzuki K, Bond JS. Intracellular Protein Catabolism. Advances in Experimental Medicine and Biology, Volume 389. Plenum Press, New York and London. 1996; 1-230, 1996.
66. Tiao G, Fagan J, Roegner V, et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest. 1996; 97: 339-48.
67. Price SR, England BK, Bailey JL, et al. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am. J. Physiol. 1994; 267: C955-C60.
68. Costelli P, Garzia-Martinez C, Llovera M, et al. Muscle protein waste in tumor-bearing rats is effectively antagonized by a 2- adrenergic agonist (Clenbuterol). Role of the ATP-ubiquitindependent proteolytic pathway. J. Clin. Invest. 1995; 95: 2367-72.
69. Llovera M, Garcia-Martinez C, Agell N, et al. Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. Int J Mol Med 1998; 2(1): 69-73.
70. LeCapitaine NJ, Wang ZQ, Dufour JP, et al. Disrupted anabolic and catabolic processes may contribute to alcohol-accentuated SAIDS-associated wasting. J Infect Dis. 2011 Oct15; 204(8): 1246-55. doi: 10.1093/infdis/jir508. PubMed PMID: 21917898; PubMedCentral PMCID: PMC3173505.
71. Molina PE, Lang CH, McNurlan M, et al. Chronic alcohol accentuates simian acquired immunodeficiency syndromeassociated wasting. Alcohol Clin Exp Res. 2008 Jan; 32(1): 138-47. Epub 2007 Nov 20. PubMed PMID: 18028526; PubMed Central PMCID: PMC3178106.
72. Attaix D, Ventadour S, Codran A, et al. The ubiquitin-proteasome system and skeletal muscle wasting. Essays Biochem. 2005; 41: 173-86.
73. Vary TC, Frost RA, Lang CH. Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2008; 294(6): R1777-R1789.
74. Franch HA, Price SR. Molecular signaling pathways regulating muscle proteolysis during atrophy. Curr Opin Clin Nutr Metab Care.2005; 8(3): 271-5.
75. Nguyen BY, Clerici M, Venzon DJ, et al. Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients. AIDS 1998; 12(8): 895-904.
76. Otis JS, Guidot DM. Procysteine stimulates expression of key anabolic factors and reduces plantaris atrophy in alcohol-fed rats. Alcohol Clin Exp Res. 2009 Aug; 33(8): 1450-9. doi: 10.1111/j.1530- 0277.2009.00975.x. Epub 2009 May 4. PubMed PMID: 19426167; PubMed Central PMCID: PMC2723178.
77. Nguyen VA, Le T, Tong M, et al. Impaired insulin/IGF signaling in experimental alcohol-related myopathy. Nutrients. 2012 Aug; 4(8): 1058-75. Epub 2012 Aug 20. PubMed PMID: 23016132; PubMed Central PMCID: PMC3448087.
78. de Alvaro C, Teruel T, Hernandez R, et al. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem. 2004; 279(17): 17070-8.
79. Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, et al. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008; 114(3): 183-94.
80. Thomas M, Langley B, Berry C, et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 2000; 275: 40235-40243.
81. Gonzalez-Cadavid, Taylor WE, Yarasheski K, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. PNAS 1998; 95: 14938-14943.
82. Bechet D, Tassa A, Taillandier D, et al. Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol. 2005 Oct; 37(10): 2098-114. Epub 2005 Mar 23. Review. PubMed PMID: 16125113.
83. Gelato MC, Mynarcik D, McNurlan MA. Soluble tumour necrosis factor alpha receptor 2, a serum marker of resistance to the anabolic actions of growth hormone in subjects with HIV disease. Clin Sci (Lond). 2002; 102(1): 85-90.
84. Frost RA, Lang CH. Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care. 2005; 8(3): 255-63.
85. Späte U, Schulze PC. Proinflammatory cytokines and skeletal muscle.Curr Opin Clin Nutr Metab Care.2004; 7(3): 265-9.
86. Fernández-Solà J, Nicolás JM, Sacanella E, et al. Low-dose ethanol consumption allows strength recovery in chronic alcoholic myopathy. QJM. 2000 Jan; 93(1): 35-40. PubMed PMID: 10623780.
87. Berg KM, Kunins HV, Jackson JL, et al. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med. 2008; 121(5): 406-18.
88. Bikle DD. Alcohol-induced bone disease. World Rev Nutr Diet 1973; 73: 53-73.
89. Saville PD. Alcohol-related skeletal disorders. Ann N Y Acad Sci 1975; 252: 287-91.
90. Kim MJ, Shim MS, Kim MK, et al. Effect of chronic alcohol ingestion on bone mineral density in males without liver cirrhosis.Korean J Intern Med.2003; 18(3): 174-80.
91. Spencer H, Rubio N, Rubio E, et al. Chronic alcoholism. Frequently overlooked cause of osteoporosis in men. Am J Med. 1986; 80(3): 393-7.
92. Malik P, Gasser RW, Kemmler G, et al. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res. 2009; 33(2): 375-81.
93. Santori C, Ceccanti M, Diacinti D, et al. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol.J Endocrinol Invest. 2008; 31(4): 321-6.
94. Laitinen K, Välimäki M. Alcohol and bone. Calcif Tissue Int. 1991; 49 Suppl: S70-3.
95. Santori C, Ceccanti M, Diacinti D, et al. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol.J Endocrinol Invest. 2008; 31(4): 321-6.
96. Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics. Am J Med. 1992 Dec; 93(6): 642-50. PubMed PMID: 1466360
97. Berg KM, Kunins HV, Jackson JL, et al. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med. 2008; 121(5): 406-18.
98. Cazanave C, Dupon M, Lavignolle-Aurillac V, et al. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS. 2008; 22(3): 395-402.
99. Thomas J, Doherty SM. HIV infection--a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003; 33(3): 281-91.
100. Bongiovanni M, Tincati C. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management. Curr Mol Med.2006; 6(4): 395-400.
101. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006; 20(17): 2165-74.
102. Vanderschueren D, Vandenput L, Boonen S, et al. Androgens and bone. Endocr Rev.2004; 25(3): 389-425.
103. Hofbauer LC, Khosla S, Dunstan CR, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000; 15(1): 2-12.
104. Michael H, Härkönen PL, Väänänen HK, et al. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res. 2005; 20(12): 2224-32.
105. Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone. 2002; 30(2): 340-6.
106. Kimble RB. Alcohol, cytokines, and estrogen in the control of bone remodeling. Alcohol Clin Exp Res. 1997; 21(3): 385-91.
107. Späte U, Schulze PC. Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004; 7(3): 265-9.
108. Bellido T, Jilka RL, Boyce BF, et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest.1995; 95(6): 2886-95.
109. Manolagas SC. Role of cytokines in bone resorption. Bone. 1995; 17(2 Suppl): 63S-67S.
110. Wang Y, Nishida S, Elalieh HZ, et al. Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res. 2006; 21(9): 1350-8.
111. Emanuele MA, Emanuele N. Alcohol and the male reproductive system. Alcohol Res Health. 2001; 25(4): 282-7.
112. Muthusami KR, Chinnaswamy P. Effect of chronic alcoholism on male fertility hormones and semen quality. Fertil Steril. 2005; 84(4): 919-24.
113. Van Thiel DH, Lester R. Alcoholism: its effect on hypothalamic pituitary gonadal function. Gastroenterology. 1976; 71(2): 318-27.
114. Barbaro G. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Am J Ther. 2006; 13(3): 248-60.
115. Kosmiski L, Kuritzkes D, Lichtenstein K, et al. Adipocyte-derived hormone levels in HIV lipodystrophy. Antivir Ther. 2003; 8: 9-15.
116. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-30.
117. Graham TE, Yang Q, Blüher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552-63.
118. Jan V, Cervera P, Maachi M, et al. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir Ther. 2004; 9(4): 555-64.
119. Haugaard SB, Andersen O, Dela F, et al. Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells. Eur J Endocrinol. 2005 Jan; 152(1): 103-12. PubMed PMID: 15762193.
120. Sevastianova K, Sutinen J, Kannisto K, et al. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab. 2008; 295(1): E85-91.
121. Addolorato G, Capristo E, Marini M, et al. Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol. 2000; 95(9): 2323-7.
122. Leggio L, Malandrino N, Ferrulli A, et al. Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical study. Alcohol Alcohol. 2009; 44(2): 211-5.
123. Jarvis CM, Hayman LL, Braun LT, et al. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women. J Cardiovasc Nurs. 2007; 22(6): 429-35.
124. Nicolás JM, Fernández-Solà J, Fatjó F, et al. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res. 2001; 25(1): 83-8.
125. Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease. IUBMB Life. 2008; 60(12): 790-7.
126. Tang H, Sebastian BM, Axhemi A, et al. Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes. Alcohol Clin Exp Res. 2012 Feb; 36(2): 214-22. doi: 10.1111/j.1530-0277.2011.01607.x. Epub 2011 Sep 6. PubMed PMID: 21895711; PubMed Central PMCID: PMC3235233.
127. Kang L, Sebastian BM, Pritchard MT, et al. Chronic ethanolinduced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin Exp Res. 2007 Sep; 31(9): 1581-8. Epub 2007 Jul 11. PubMed PMID: 17624994.
128. Molina PE. Alcohol--intoxicating roadblocks and bottlenecks in hepatic protein and lipid metabolism. Am J Physiol Endocrinol Metab. 2008; 295(1): E1-2.
129. Worrall S, Wilce PA. The effect of chronic ethanol feeding on cytokines in a rat model of alcoholic liver disease. Alcohol Suppl. 1994; 2: 447-51.
130. Sonntag WE, Boyd RI. Diminished insulin-like growth factor-1 levels after chronic ethanol: relationship to pulsatile growth hormone release. Alcohol Clin Exp Res 1989; 13: 3-7.
131. Saito T, Kobatake K, Ozawa H, et al. Aromatic and branched-chain amino acid levels in alcoholics. Alcohol 1994; 29: 133-5.
132. Shaw S, Lieber CS. Plasma amino acids in the alcoholic: nutritional aspects. Alcohol Clin Exp Res 1983; 7(1): 22-27.
133. Fernandez-Checa, JC Kaplowitz N, Colell A, et al. Oxidative stress and alcoholic liver disease. Alcohol Health & Research World 1997; 21: 321-4.
134. Cederbaum, A.I. Introduction-Serial review: Alcohol, oxidative stress, and cell injury. Free Radical Biology & Medicine 2001; 31: 1524-6.
135. Nanji AA, Zhao S, Sadrzadeh SM, et al. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-treated ethanol-fed rats. Alcoholism: Clinical and Experimental Research 1994; 8: 1280-5.
136. Preedy VR, Adachi J, Asano M, et al. Free radicals in alcoholic myopathy: indices of damage and preventive studies. Free Radic Biol Med. 2002; 32(8): 683-7.
137. Russell ST, Eley H, Tisdale MJ. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysisinducing factor and angiotensin II. Cell Signal. 2007; 19(8): 1797-806.
138. Otis JS, Brown LA, Guidot DM. Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats. Muscle Nerve. 2007; 36(6): 842-8.
139. Bai XC, Lu D, Liu AL, et al. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem. 2005; 280(17): 17497-506.
140. Grassi F, Tell G, Robbie-Ryan M, et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci U S A. 2007; 104(38): 15087-92.
141. Russell ST, Eley H, Tisdale MJ. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysisinducing factor and angiotensin II. Cell Signal. 2007; 19(8): 1797-806.
142. Eriksson JW. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance. FEBS Lett. 2007; 581(19): 3734-42.
143. McClain CJ, Song Z, Barve SS, et al. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol.2004; 287: G497-502.
144. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 1989; 9: 349-351.
145. Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver.Alcohol Clin Exp Res. 2009; 33(2): 191-205.
146. Szabo G, Mandrekar P, Oak S, et al. Effect of ethanol on inflammatory responses. Implications for pancreatitis. Pancreatology. 2007; 7(2-3): 115-23.
147. Lang CH, Krawiec BJ, Huber D, et al. Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2006; 290(4): R963-72.
148. Frost RA, Lang CH. Alteration of somatotropic function by proinflammatory cytokines. J Anim Sci.2004; 82 E-Suppl: E100-E109.
149. Manolagas SC. Role of cytokines in bone resorption. Bone. 1995; 17(2 Suppl): 63S-67S.
150. Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007; 65(12 Pt 2): S147-51.
151. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008; 29(24): 2959-71.
152. Lester R, Van Thiel DH. Gonadal function in chronic alcoholic men.Adv Exp Med Biol. 1977; 85A: 399-413.
153. Isidori AM, Lenzi A. Risk factors for androgen decline in older males: lifestyle, chronic diseases and drugs. J Endocrinol Invest. 2005; 28(3 Suppl): 14-22.
154. Ronis MJ, Wands JR, Badger TM, et al. Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exp Res. 2007; 31(8): 1269-85.
155. Röjdmark S, Brismar K. Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence. J Endocrinol Invest. 2001; 24(7): 476-82.
156. Frost RA, Fuhrer J, Steigbigel R, et al. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin Endocrinol 1996; 44: 501-14.
157. Nguyen BY, Clerici M, Venzon DJ, et al. Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients. AIDS 1998; 12(8): 895-904.
158. Poretsky L, Can S, Zumoff B. Testicular dysfunction in human immunodeficiency virus-infected men. Metabolism. 1995; 44(7): 946-53.
159. Alonso K, Pontiggia P, Mendenica R, et al. Cytokine patterns in adults with AIDS. Immunol Invest 1997; 26: 341-350.
160. Rimaniol AC, Zylberberg H, Zavala F, et al. Inflammatory cytokines and inhibitors in HIV infection: correlation between interleukin-1 receptor antagonist and weight loss. AIDS 1996; 10: 1349-56.
161. Alonso K, Pontiggia P, Mendenica R, et al. Cytokine patterns in adults with AIDS. Immunol Invest 1997; 26: 341-50.
162. Rimaniol AC, Zylberberg H, Zavala F, et al. Inflammatory cytokines and inhibitors in HIV infection: correlation between interleukin-1 receptor antagonist and weight loss. AIDS 1996; 10: 1349-56.
163. Treitinger A, Spada C, Verdi JC, et al. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur J Clin Invest. 2000; 30(5): 454-9.
164. Israël N, Gougerot-Pocidalo MA. Oxidative stress in human immunodeficiency virus infection. Cell Mol Life Sci. 1977; 53(11- 12): 864-70.
165. Centers for Disease Control and Prevention. 1998. Trends in the HIV and AIDS epidemic.
166. Samet JH, Cheng DM, Libman H, et al. Alcohol consumption and HIV disease progression.J Acquir Immune Defic Syndr. 2007; 46(2): 194-9.
167. Miguez MJ, Shor-Posner G, Morales G, et al. HIV treatment in drug abusers: impact of alcohol use. Addict Biol. 2003; 8(1): 33-7.
168. Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006; 43(4): 411-7.
169. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001; 33(8): 1417-23
170. Lucas GM, Gebo KA, Chaisson RE, et al. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002; 16(5): 767-74.
171. Parsons JT, Rosof E, Mustanski B. The temporal relationship between alcohol consumption and HIV-medication adherence: a multilevel model of direct and moderating effects. Health Psychol. 2008; 27(5): 628-37.
172. Samet JH, Horton NJ, Meli S, et al. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004; 28(4): 572-7.
173. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011; 52(6): 793-800.
174. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006; 66(6): 769-89.
175. Palepu A, Tyndall MW, Li K, et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health. 2003; 80(4): 667-75.
176. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006; 41(3): 285-97.
177. Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998; 339(5): 307-11
178. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis. 2001; 33(5): 700-5.
179. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000; 133(1): 21-30.
180. Race E, Dam E, Obry V, Paulous S, Clavel F. Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies. AIDS. 1999; 13(15): 2061-8.
181. Raj A, Reed E, Santana MC, Walley AY, Welles SL, Horsburgh CR, et al. The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. Drug Alcohol Depend. 2009; 101(1-2): 101-6.
182. Shuper PA, Joharchi N, Irving H, Rehm J. Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis. AIDS Behav. 2009; 13(6): 1021-36.
183. Seth P, Wingood GM, DiClemente RJ, Robinson LS. Alcohol use as a marker for risky sexual behaviors and biologically confirmed sexually transmitted infections among young adult African-American women. Womens Health Issues. 2011; 21(2): 130-5.
184. Henrich TJ, Lauder N, Desai MM, Sofair AN. 2008. Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics. J Community Health. 33(2): 69-77.
185. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002 Aug 8; 347(6): 385-94. PubMed PMID: 12167680.